Alnylam Pharmaceuticals Inc logo

Alnylam Pharmaceuticals Inc

LTS:0HD2 (USA)   Ordinary Shares
$ 147.90 (-21.85%) Apr 29
At Loss
Market Cap:
$ 18.63B
Enterprise V:
$ 17.50B
Volume:
17.00
Avg Vol (2M):
17.00
Also Trade In:
Volume:
17.00
At Loss
Avg Vol (2M):
17.00

Alnylam Pharmaceuticals Inc Valuation Measures